Effects of immune checkpoint inhibitors on B cells: relationship to immune-related adverse events

Pisetsky David S.

首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Effects of immune checkpoint inhibitors on B cells: relationship to immune-related adverse events

【24h】

Effects of immune checkpoint inhibitors on B cells: relationship to immune-related adverse events

机译：免疫检查点抑制剂对B细胞的影响：免疫相关不良事件的关系

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research》 |2018年第6期|共2页
作者
Pisetsky David S.;
展开▼
作者单位

Duke Univ Med Ctr Dept Med Durham NC 27710 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
disease activity; polymyalgia rheumatica; reactive arthritis;

机译：疾病活动;多孔血小益症;活性关节炎;

相似文献

外文文献
中文文献
专利

1. Blood and Histopathological Biomarkers of Immune-related Adverse Effects of Treatment with Immune Checkpoint Inhibitors [J] . Yogesh Jheengut, Yi Qian Liu, Ling Xiang Liu 肿瘤营养学杂志(英文) . 2019,第004期
2. Blood and Histopathological Biomarkers of Immune-related Adverse Effects of Treatment with Immune Checkpoint Inhibitors [J] . Yogesh Jheengut, Yi Qian Liu, Ling Xiang Liu 肿瘤营养学杂志（英文） . 2019,第004期
3. Effects of immune checkpoint inhibitors on B cells: relationship to immune-related adverse events [J] . Pisetsky David S. Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2018,第6期

机译：免疫检查点抑制剂对B细胞的影响：免疫相关不良事件的关系
4. Association between pretreatment neutrophil-to-lymphocyte ratio and immune-related adverse events due to immune checkpoint inhibitors in patients with non-small cell lung cancer [J] . Airi Fujimoto, Gouji Toyokawa, Yoshimichi Koutake, Thoracic cancer. . 2021,第15期

机译：非小细胞肺癌患者免疫检查点抑制剂的预处理中性粒细胞与淋巴细胞比率和免疫相关不良事件的关系
5. Comparative incidence of immune-related adverse events and hyperprogressive disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors with and without chemotherapy [J] . Matsuo Norikazu, Azuma Koichi, Kojima Takashi, Investigational new drugs. . 2021,第4期

机译：非小细胞肺癌接受免疫检查点抑制剂的免疫相关不良事件和超前疾病的比较发病率
6. Identification of Patients with Immune-related Adverse Events from Clinical Notes using Machine Learning [C] . Samir Gupta, Anas Belouali, Neil Shah, IEEE International Conference on Healthcare Informatics . 2020

机译：使用机器学习鉴定免疫相关不良事件的患者
7. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
8. Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma [O] . Sarah Abou Alaiwi, Wanling Xie, Amin H Nassar, 2020

机译：在转移性肾细胞癌中临床上明显的免疫相关不良事件发生后重启免疫检查点抑制剂的安全性和有效性
9. Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma [O] . Sarah Abou Alaiwi, Wanling Xie, Amin H Nassar, 2020

机译：在临床显着的免疫相关不良事件中重新启动免疫检查点抑制剂的安全性和有效性，转移性肾细胞癌
10. Phase 1 Trial of an Immune Checkpoint Inhibitor plus Stereotactic Ablative Radiotherapy in Patients with Inoperable Stage I Non-Small Cell Lung Cancer. [R] . Kelly, K., Monjazeb, A., Daly, M., 2017

机译：免疫检查点抑制剂加立体定向消融放疗治疗不能手术的I期非小细胞肺癌的1期试验。

Effects of immune checkpoint inhibitors on B cells: relationship to immune-related adverse events

著录项

相似文献

相关主题

期刊订阅